Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Xuanyan Xu

Xuanyan Xu

Solution Marketing Manager at Elsevier

Connect with Xuanyan Xu on LinkedIn
Follow Xuanyan Xu on Twitter

About the author:

Xuanyan joined Elsevier in October 2016 and currently works as a solution marketing manager. She holds a master’s degree in biochemistry and science-based business. Prior to Elsevier, she worked in QIAGEN and was involved in managing various parts of the life science portfolio. Xuanyan’s interests span several emerging fields, particularly pharmacovigilance and systematic review researches.

Posts by Xuanyan Xu

In pharmacovigilance, effective search strings are key

Posted on February 9th, 2018 in Pharmacovigilance

A key component of any pharmacovigilance strategy is building search strings that successfully identify potential adverse events, which must be reported to regulatory agencies. If the query returns too narrow a result set, adverse events may be missed. Continue reading “In pharmacovigilance, effective search strings are key” »

FDA Speeds Up Generic Approval Process

Posted on August 30th, 2017 in Pharmacovigilance

Healthcare has been in the spotlight for much of the year so far, as Congress has wrestled with the difficult question of how to make it both better and more affordable.

Continue reading “FDA Speeds Up Generic Approval Process” »

Building a balanced search formula for pharmacovigilance and literature monitoring

Posted on March 21st, 2017 in Pharmacovigilance

Adverse drug reactions are an important risk for patient safety and have significant impact on the costs of health systems. A rise in number of diseases has consequently led to a rise in number of drug consumption, which has also brought about an increase in the number of adverse drug events and drug toxicity cases. Continue reading “Building a balanced search formula for pharmacovigilance and literature monitoring” »

Debates on Pharmacovigilance – What’s new and trending

Posted on March 2nd, 2017 in Pharmacovigilance

Fleming’s Pharmacovigilance & Risk Management Strategies Forum is always an excellently organized event, attended by industry leaders, policy makers and legislators. Continue reading “Debates on Pharmacovigilance – What’s new and trending” »

  1. 1
  2. 2